Disordered Signaling in Myeloproliferative Neoplasms

Mar 1, 2017 by in HEMATOLOGY Comments Off on Disordered Signaling in Myeloproliferative Neoplasms

The human myeloproliferative neoplasms (MPN) have long been associated with abnormal responses to cytokines and activation of signaling pathways, although the exact molecular mechanisms underlying these observations were unknown. This…

read more

Merkel Cell Carcinoma

Mar 1, 2017 by in HEMATOLOGY Comments Off on Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a rare but aggressive carcinoma of the skin, arising most commonly in sun-exposed sites of elderly patients. The diagnosis is based on characteristic histopathologic features….

read more

Current Treatment of Anal Squamous Cell Carcinoma

Mar 1, 2017 by in HEMATOLOGY Comments Off on Current Treatment of Anal Squamous Cell Carcinoma

The primary aim of anal cancer treatment is loco-regional control with preservation of anal function. Phase III trials consistently demonstrate radiotherapy with concurrent 5FU and mitomycin (MMC) chemoradiation is the…

read more

Neoplasms of the Appendix

Mar 1, 2017 by in HEMATOLOGY Comments Off on Neoplasms of the Appendix

The purpose of this article is to update the medical community on the current management of patients with appendiceal neoplasms. The authors discuss clinical evidence of medical and surgical treatment…

read more

Urethral Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Urethral Cancer

Urethral carcinoma is a rare tumor with predominantly poor survival. Both the disease and its treatment can affect both sexual and urinary function. The natural history of urethral carcinoma varies,…

read more
Get Clinical Tree app for offline access